Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
BMC Cardiovasc Disord. 2021 Mar 26;21(1):154. doi: 10.1186/s12872-021-01957-z.
Appropriate use criteria (AUC) have been developed in response to growth in cardiac imaging utilization and concern regarding associated costs. Cardiac computed tomography angiography (CCTA) has emerged as an important modality in the evaluation of coronary artery disease, however its appropriate utilization in actual practice is uncertain. Our objective was to determine the appropriate utilization of CCTA in a large quaternary care institution and to compare appropriate utilization pre and post publication of the 2013 AUC guidelines. We hypothesized that the proportion of appropriate CCTA utilization will be similar to those of other comparable cardiac imaging modalities and that there would be a significant increase in appropriate use post AUC publication.
We employed a retrospective cohort study design of 2577 consecutive patients undergoing CCTA between January 1, 2012 and December 30, 2016. An appropriateness category was assigned for each CCTA. Appropriateness classifications were compared pre- and post- AUC publication via the chi-square test.
Overall, 83.5% of CCTAs were deemed to be appropriate based on the AUC. Before the AUC publication, 75.0% of CCTAs were classified as appropriate whereas after the AUC publication, 88.0% were classified as appropriate (p < 0.001). The increase in appropriate utilization, when extrapolated to the Medicare population of the United States, was associated with potential cost savings of approximately $57 million per year.
We report a high rate of appropriate use of CCTA and a significant increase in the proportion of CCTAs classified as appropriate after the AUC publication.
为应对心脏成像利用率的增长以及对相关成本的担忧,制定了适宜性使用标准(AUC)。心脏计算机断层扫描血管造影(CCTA)已成为评估冠状动脉疾病的重要手段,但其在实际应用中的适宜性尚不确定。我们的目的是确定在大型四级保健机构中 CCTA 的适宜使用情况,并比较 AUC 指南 2013 年发布前后的适宜使用情况。我们假设,CCTA 的适宜使用率将与其他可比心脏成像方式相似,并且在 AUC 发布后,适宜使用量将显著增加。
我们采用回顾性队列研究设计,对 2012 年 1 月 1 日至 2016 年 12 月 30 日期间连续进行的 2577 例 CCTA 患者进行了研究。为每位 CCTA 分配了一个适宜性类别。通过卡方检验比较 AUC 发布前后的适宜性分类。
总体而言,根据 AUC,83.5%的 CCTA 被认为是适宜的。在 AUC 发布之前,75.0%的 CCTA 被归类为适宜,而在 AUC 发布之后,88.0%的 CCTA 被归类为适宜(p<0.001)。如果将适宜使用率外推到美国医疗保险人群,每年可节省约 5700 万美元的潜在成本。
我们报告了 CCTA 的高适宜使用率,并且在 AUC 发布后,被归类为适宜的 CCTA 的比例显著增加。